Biosimilars on the rise
05. Oktober 2024
In the Effecten Spiegel financial podcast, Formycon CFO Enno Spillner talks about biosimilars, the market's growth prospects and Formycon's strategy and recent regulatory successes. The podcast is available in German.
You are currently seeing a placeholder content of YouTube. To access the actual content, click on the button below. Please note that data will be passed on to third-party providers.
More information
